Leveraging our astroglia-enriched organoid models, which exhibit enhanced NRXN-NLGN signaling, we employed hESCs carrying the NLGN3 R451C mutation to develop organoids and further explore astroglial pathology in autism. Here, NLGN3 is linked to autism.